Neola Medical released the Q1 report for 2023 last week. At the same time as they create an interest among neonatal intensive care units around Europe, there is intensive focus on verification before clinical studies. BioStock contacted CEO Hanna Sjöström for a comment on the Q1 report.

Read the article here: Neola Medical kicks off the market preparations

Read the report and the press release (in Swedish) here: Press release